SCHEMBL17207206

SCHEMBL17207206

Cc1cc(N(C)Cc2ccccc2)ncn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.57
▸ TSHR P16473 3/20 0.57
▸ MAPT P10636 2/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ LMNA P02545 6/20 0.46
▸ HTT P42858 2/20 0.46
▸ PIK3CD O00329 1/20 0.46
▸ PIK3R1 P27986 1/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ ERAP1 Q9NZ08 1/20 0.45
▸ CSF1R P07333 3/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ MAP2K7 O14733 1/20 0.44
▸ LOXL2 Q9Y4K0 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ BRD4 O60885 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ GLA P06280 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17688925 0.80 PTGS2 (0.45) SMN1; SMN2TSHRMAPTKMT2ALMNA
SCHEMBL792933 0.73 CYP1A2 (0.32) TSHRKMT2ALMNAALDH1A1USP2
SCHEMBL19998584 0.72 SMN1; SMN2 (0.56) SMN1; SMN2TSHRMAPTKMT2ALMNA
SCHEMBL15114892 0.72 HCAR3 (0.39) KMT2ALMNAHIF1AALDH1A1USP2
SCHEMBL4747138 0.72 CHRM2 (0.63) SMN1; SMN2TSHRMAPTKMT2ALMNA
SCHEMBL11567282 0.71 GAA (0.49) SMN1; SMN2TSHRMAPTKMT2ALMNA
SCHEMBL14872345 0.70 POLB (0.47) LMNAKDM4EALDH1A1USP2CYP1A2
SCHEMBL792749 0.70 JAK3 (0.31) LMNAALDH1A1USP2CYP1A2GLA
SCHEMBL1671084 0.69 CYP1A2 (0.48) TSHRMAPTKMT2AALDH1A1CYP1A2
SCHEMBL2954326 0.69 HCRTR1 (0.55) LMNAKDM4EALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2922841-B1 ALKYL-AMIDE-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES BRISTOL MYERS SQUIBB CO (US) 2017-06-07 — — EP disclosed
US-9315494-B2 Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses BRISTOL-MYERS SQUIBB COMPANY (US) 2016-04-19 — — US disclosed
US-9315494-B2 Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses BRISTOL-MYERS SQUIBB COMPANY (US) 2016-04-19 — — US disclosed
US-20150307483-A1 ALKYL-AMIDE-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES BRISTOL-MYERS SQUIBB COMPANY 2015-10-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307483-A1 ALKYL-AMIDE-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES IFNG, TYK2, IFNAR1 SMN1; SMN2 3661/4885TSHR 564/4885MAPT 3519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback